(S (NP (NP (NNP Drug)) (VP (VBG repositioning) (NP (-LRB- -LRB-) (NNP DR) (-RRB- -RRB-)))) (VP (VBZ refers) (PP (IN to) (NP (NP (NN identification)) (PP (IN of) (NP (NP (JJ novel) (NNS indications)) (PP (IN for) (NP (DT the) (VBN approved) (NNS drugs)))))))) (. .))
(S (NP (NP (NP (DT The) (NN requirement)) (PP (IN of) (NP (NP (JJ huge) (NN investment)) (PP (IN of) (NP (NN time)))))) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NN money) (CC and) (NN risk)) (PP (IN of) (NP (NP (NN failure)) (PP (IN in) (NP (JJ clinical) (NNS trials))))))) (VP (VBP have) (VP (VBN led) (PP (IN to) (NP (NP (NN surge)) (PP (IN in) (NP (NN interest))))) (PP (IN in) (NP (NP (NN drug)) (VP (VBG repositioning)))))) (. .))
(S (NP (NNP DR)) (VP (VP (VBZ exploits) (NP (NP (CD two) (JJ major) (NNS aspects)) (VP (VBN associated) (PP (IN with) (NP (NNS drugs) (CC and) (NNS diseases)))))) (: :) (VP (NP (NP (NN existence)) (PP (IN of) (NP (NN similarity)))) (PP (IN among) (NP (NNS drugs)))) (CC and) (VP (PP (IN among) (NP (NNS diseases))) (PP (IN due) (IN to) (NP (NP (PRP$ their) (VBN shared) (JJ involved) (NNS genes)) (CC or) (NP (NP (NNS pathways)) (CC or) (NP (JJ common) (JJ biological) (NNS effects))))))) (. .))
(S (NP (NP (VBG Existing) (NNS methods)) (PP (IN of) (S (VP (VBG identifying) (NP (NML (NN drug) (HYPH -) (NN disease)) (NN association)))))) (ADVP (RB majorly)) (VP (VBP rely) (PP (IN on) (NP (NP (DT the) (NN information)) (ADJP (JJ available) (PP (IN in) (NP (DT the) (JJ structured) (NNS databases)))))) (ADVP (RB only))) (. .))
(S (PP (IN On) (NP (DT the) (JJ other) (NN hand))) (, ,) (NP (NP (JJ abundant) (NN information)) (ADJP (JJ available) (PP (IN in) (NP (NP (NN form)) (PP (IN of) (NP (NP (JJ free) (NNS texts)) (PP (IN in) (NP (NML (JJ biomedical) (NN research)) (NNS articles))))))))) (VP (VBP are) (RB not) (VP (VBG being) (ADVP (RB fully)) (VP (VBN exploited)))) (. .))
(S (NP (NP (NP (NN Word) (HYPH -) (NN embedding)) (CC or) (S (VP (VBG obtaining) (NP (NP (NN vector) (NN representation)) (PP (IN of) (NP (NNS words)))) (PP (IN from) (NP (NP (DT a) (JJ large) (NNS corpora)) (PP (IN of) (NP (JJ free) (NNS texts)))))))) (VP (VBG using) (NP (JJ neural) (NN network) (NNS methods)))) (VP (VBP have) (VP (VBN been) (VP (VBN shown) (S (VP (TO to) (VP (VB give) (NP (JJ significant) (NN performance)) (PP (IN for) (NP (JJ several) (NML (JJ natural) (NN language) (NN processing)) (NNS tasks))))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN work))) (NP (PRP we)) (VP (VBP propose) (NP (NP (DT a) (JJ novel) (NN way)) (PP (IN of) (NP (NN representation) (NN learning)))) (S (VP (TO to) (VP (VB obtain) (NP (NP (NNS features)) (PP (IN of) (NP (NNS drugs) (CC and) (NNS diseases)))) (PP (IN by) (S (VP (VBG combining) (NP (JJ complementary) (NN information)) (S (ADJP (JJ available) (PP (IN in) (NP (NP (ADJP (JJ unstructured)) (NNS texts)) (CC and) (NP (VBN structured) (NNS datasets))))))))))))) (. .))
(S (ADVP (RB Next)) (NP (PRP we)) (VP (VBP use) (NP (NP (NN matrix) (NN completion) (NN approach)) (PP (IN on) (NP (DT these) (NN feature) (NNS vectors)))) (S (VP (TO to) (VP (VB learn) (NP (NP (NN projection) (NN matrix)) (PP (IN between) (NP (NML (NN drug) (CC and) (NN disease)) (NN vector) (NNS spaces)))))))) (. .))
(S (NP (DT The) (JJ proposed) (NN method)) (VP (VBZ has) (VP (VBN shown) (NP (JJ competitive) (NN performance)) (PP (IN with) (NP (NML (NML (NN state)) (HYPH -) (PP (IN of) (HYPH -) (NP (DT the) (HYPH -) (NN art)))) (NNS methods))))) (. .))
(S (ADVP (RB Further)) (, ,) (NP (NP (DT the) (NN case) (NNS studies)) (PP (IN on) (NP (NP (NNP Alzheimer) (POS 's)) (CC and) (NP (NN Hypertension) (NNS diseases))))) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (DT the) (VBN predicted) (NNS associations)) (VP (VBP are) (VP (VBG matching) (PP (IN with) (NP (DT the) (VBG existing) (NN knowledge))))))))) (. .))
